COMMUNIQUÉS West-GlobeNewswire

Kno2 Designated as a Qualified Health Information Network (QHIN) Under TEFCA
12/02/2024
BOISE, Idaho, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Kno2 is proud to announce its designation as a Qualified Health Information Network TM (QHIN TM ) under the Trusted Exchange Framework and Common Agreement SM (TEFCA SM [...]
Caregivers Cheer First Patients at New Intermountain Primary Children’s Hospital, Miller Family Campus in Lehi, Utah
12/02/2024
Lehi, Utah, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The first three patients at the new Intermountain Primary Children’s Hospital, Larry H. and Gail Miller Family Campus in Lehi were welcomed with cheers and applause from [...]
OneMedNet iRWD® Draws Attention at Clinical Trials Meeting
12/02/2024
MINNEAPOLIS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), is receiving an enthusiastic [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2024
12/02/2024
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024
12/02/2024
Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]
Freeline Shareholders Approve Acquisition by Syncona
12/02/2024
LONDON, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (“Freeline”) and Syncona Ltd (“Syncona”) today announced that Freeline’s shareholders have approved the proposal for Bidco 1354 [...]
Novo Nordisk A/S - share repurchase programme
12/02/2024
Bagsværd, Denmark, 12 February 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]
Canary Completes First-in-Human Trial of Cardiac Auscultation Monitoring Sensor
12/02/2024
The Cardiac Auscultation monitoring device was trialed for use with heart failure patients as an adjunct to care in monitoring the effectiveness of congestive heart failure medication management The limited clinical [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12/02/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]
CartoChrome Aids Home Buyers with Health Score, Addressing a $150 Billion Healthcare Accessibility Issue
12/02/2024
LOS ANGELES, Feb. 12, 2024 (GLOBE NEWSWIRE) -- In an ambitious effort to address a $150 billion problem in healthcare accessibility, CartoChrome has launched a solution that expertly integrates healthcare data into the [...]
Assure Holdings Corp. Announces Business Combination with Danam Health, Inc.
12/02/2024
Danam Health, Inc., a private pharmaceutical and healthcare services company, to merge with Assure Holdings Corp. in an all-stock transaction DENVER, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure”) ( [...]
Solera Chief Medical Officer Dr. Byron Crowe Recognized as One of Modern Healthcare’s 40 Under 40
12/02/2024
CHICAGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Solera Health , the premier technology platform for connecting people seamlessly and easily to health solutions that work, today announced that Dr. Byron Crowe , the company’s [...]
HeartSciences Expands its Scientific Advisory Board
12/02/2024
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology [...]
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
12/02/2024
Boca Raton, Florida, Feb. 12, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s [...]
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
12/02/2024
Increases number of bacteria species detected with addition of Acinetobacter baumannii LEXINGTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis- [...]
BlueSprig Pediatrics Sponsors Armani Williams Ahead of the Daytona ARCA 200
12/02/2024
The partnership with Williams, who has autism, will bring BlueSprig’s work with children with autism to the spotlight DAYTONA BEACH, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Blue Sprig Pediatrics, Inc. (BlueSprig) , a [...]
Signati™ Medical, Inc. Announces Board Member Dr. Jones Joins Urology Austin
12/02/2024
Providence, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin. Dr. Jones has been on the [...]
Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024
12/02/2024
- Study results highlight potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s - SOUTH SAN FRANCISCO, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Jaya Biosciences, Inc [...]
Accelus Strengthens Leadership with New Board Appointments
12/02/2024
Accelus CEO & Industry Veteran Kevin McGann and High-Performance Management Expert Bernie Haffey to Join as New Directors PALM BEACH GARDENS, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Accelus , a privately held [...]

Pages